COVID-19 Vaccine Acceptability and Its Determinants in Mozambique: An Online Survey

Dulá, Janeth; Mulhanga, Alexandre; Nhanombe, Armindo; Cumbi, Laurentino; Júnior, Antônio Rodrigues Ferreira; Gwatsvaira, Joe; Fodjo, Joseph Nelson Siewe; Villela, Edlaine Faria de Moura; Chicumbe, Sérgio; Colebunders, Robert

doi:10.3390/vaccines9080828

Cited by 57 publications

(57 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Heads of households who were confident that COVID-19 vaccines were completely safe were 28 times more likely to intend to get vaccinated compared to those who lacked confidence in the safety of COVID-19 vaccines. These results are consistent with findings in other African settings that indicate that COVID-19 vaccine safety is a major concern and determinant of vaccine intentions and uptake [ 16 , 19 , 20 , 27 ]. Prior research on childhood vaccines has similarly demonstrated an association between perceived vaccine safety and vaccine intentions or uptake [ 12 , 15 ].…”

Section: Discussionsupporting

confidence: 92%

“…Recent studies focused on the uptake of COVID-19 vaccines have identified similar factors with the major barriers being concerns about safety and side effects, and a general lack of trust in governments and the pharmaceutical companies that developed them [ 16 , 17 , 18 , 19 , 20 , 21 ]. A study by the Africa Centers for Disease Control and Prevention found that willingness to accept COVID-19 vaccines across 15 African countries ranged from 59% to 94% [ 21 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Factors Associated with COVID-19 Vaccine Intentions in Eastern Zimbabwe: A Cross-Sectional Study

McAbee

Tapera²,

Kanyangarara

2021

Vaccines

View full text Add to dashboard Cite

Vaccines are one of the most effective public health strategies to protect against infectious diseases, yet vaccine hesitancy has emerged as a global health threat. Understanding COVID-19 knowledge and attitudes and their association with vaccine intentions can help the targeting of strategies to increase vaccination uptake and achieve herd immunity. The goal of this study was to assess COVID-19 knowledge, attitudes, and behaviors, and identify factors associated with COVID-19 vaccine intentions among heads of households in Manicaland Province, Zimbabwe. A cross-sectional survey was conducted in May 2021 among 551 randomly selected households. Data were collected on socio-demographic characteristics, and knowledge, attitudes, and behaviors regarding COVID-19 and the vaccines. More than half (55.7%) of the respondents reported intending to vaccinate themselves or their households. Multivariate logistic regression indicated that the likelihood of vaccine intentions was most strongly associated with confidence in vaccine safety. Additionally, the odds of intending to get vaccinated were significantly higher among heads of households who were male, had a higher level of education, and identified vaccination and face mask usage as prevention measures. Among perceived motivators to vaccinate, recommendations from the World Health Organization and availability of the vaccine free of charge increased the likelihood of vaccine intentions, while country of vaccine manufacturer posed a barrier to vaccine intentions. As the vaccine rollout in Zimbabwe continues, efforts to increase COVID-19 vaccination coverage and achieve herd immunity should target females and less educated populations and be tailored to address concerns about vaccine safety and country of manufacturer.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Introductionmentioning

confidence: 99%

Factors Associated with COVID-19 Vaccine Intentions in Eastern Zimbabwe: A Cross-Sectional Study

McAbee

Tapera²,

Kanyangarara

2021

Vaccines

View full text Add to dashboard Cite

show abstract

“…A self-administered electronic survey was conducted in Mozambique in March 2021 and involved 1878 respondents including healthcare workers. 33 This study reported an overall COVID-19 vaccine acceptance rate of 71.4%, with a higher rate of 86.6% among healthcare workers and 64.8% among other respondents. 33 A large study by Solís…”

Section: Mozambiquementioning

confidence: 65%

A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review

Sallam¹,

Alsanafi²,

Sallam³

2022

JMDH

163

121

View full text Add to dashboard Cite

The delay or refusal of vaccination, which defines vaccine hesitancy, is a major challenge to successful control of COVID-19 epidemic. The huge number of publications addressing COVID-19 vaccine hesitancy necessitates periodic review to provide a concise summary of COVID-19 vaccine acceptance rates worldwide. In the current narrative review, data on COVID-19 vaccine acceptance rates were retrieved from surveys in 114 countries/ territories. In East and Southern Africa (n = 9), the highest COVID-19 vaccine acceptance rate was reported in Ethiopia (92%), while the lowest rate was reported in Zimbabwe (50%). In West/ Central Africa (n = 13), the highest rate was reported in Niger (93%), while the lowest rate was reported in Cameroon (15%). In Asia and the Pacific (n = 16), the highest rates were reported in Nepal and Vietnam (97%), while the lowest rate was reported in Hong Kong (42%). In Eastern Europe/Central Asia (n = 7), the highest rates were reported in Montenegro (69%) and Kazakhstan (64%), while the lowest rate was reported in Russia (30%). In Latin America and the Caribbean (n = 20), the highest rate was reported in Mexico (88%), while the lowest rate was reported in Haiti (43%). In the Middle East/North Africa (MENA, n = 22), the highest rate was reported in Tunisia (92%), while the lowest rate was reported in Iraq (13%). In Western/Central Europe and North America (n = 27), the highest rates were reported in Canada (91%) and Norway (89%), while the lowest rates were reported in Cyprus and Portugal (35%). COVID-19 vaccine acceptance rates ≥60% were seen in 72/114 countries/territories, compared to 42 countries/territories with rates between 13% and 59%. The phenomenon of COVID-19 vaccine hesitancy appeared more pronounced in the MENA, Europe and Central Asia, and Western/ Central Africa. More studies are recommended in Africa, Eastern Europe and Central Asia to address intentions of the general public to get COVID-19 vaccination.

show abstract

“…Some other issues were related to the perceived effectiveness of the vaccine, and willingness to protect others had been reported to influence the acceptance of COVID-19 vaccines [ 29 ]. A recent study conducted in Mozambique showed that the concerns about the effectiveness of vaccines were more frequently reported than the safety concerns (52% vs. 29.6%), which underpinned that vaccine hesitancy is significantly affected by the perceived benefit of getting vaccinated [ 30 ]. Vaccine hesitancy is a complex global issue involving differences in sociodemographic and external factors, and thus tailored strategies to local intervention must be implemented in the specific population [ 19 , 31 ].…”

Section: Discussionmentioning

confidence: 99%

COVID-19 Vaccination Attitudes, Perceptions, and Side Effect Experiences in Malaysia: Do Age, Gender, and Vaccine Type Matter?

et al. 2021

View full text Add to dashboard Cite

This study aimed to investigate the attitudes, perceptions, and experiences of side effects with the COVID-19 vaccines in Malaysia among participants in the National Vaccination Program. A cross-sectional survey was conducted among a sample of vaccine-eligible and vaccinated individuals in Malaysia between May and July 2021. A total of 428 respondents completed the survey. A vast majority (98.6%) of the respondents had registered to be vaccinated. Twenty participants (4.7%) expressed concerns about either registering or receiving the COVID-19 vaccination, mainly due to their uncertainty of vaccine safety. Approximately 77.5% received their vaccinations. Of them, 76.8% had experienced vaccine-related side effects. About 40% of the side effects occurred more with the second dose, particularly those who received the Pfizer-BioNTech vaccine (p < 0.0005). Pain at the injection site (61.1%) and tiredness (48.8%) were the most reported side effects. Compared to those aged ≥60 years, all age groups were more likely to exhibit vaccine-related side effects; meanwhile, males (OR: 0.51, 95% CI: 0.27–0.93) were less likely to experience side effects than females. Those who received the Sinovac vaccine were at lower risk of experiencing side effects (OR: 0.08, 95% CI: 0.03–0.22) and were more likely to report fewer side effects than Pfizer-BioNTech (p = 0.012) and Oxford-AstraZeneca groups (p = 0.001). The overall attitudes toward the COVID-19 vaccination program were positive. Several differences in the experiences of vaccine-related side effects, in terms of prevalence and numbers, were attributed to age, gender, and received vaccine type.

show abstract

COVID-19 Vaccine Acceptability and Its Determinants in Mozambique: An Online Survey

Cited by 57 publications

References 24 publications

Factors Associated with COVID-19 Vaccine Intentions in Eastern Zimbabwe: A Cross-Sectional Study

Factors Associated with COVID-19 Vaccine Intentions in Eastern Zimbabwe: A Cross-Sectional Study

A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review

COVID-19 Vaccination Attitudes, Perceptions, and Side Effect Experiences in Malaysia: Do Age, Gender, and Vaccine Type Matter?

Contact Info

Product

Resources

About